Effect of Intensive Atorvastatin Therapy on Prostaglandin E2 Levels and Metalloproteinase-9 Activity in the Plasma of Patients With Non-ST-Elevation Acute Coronary Syndrome††Conflicts of interest: Drs. Egido and Tuñón have participated on advisory boards and have been invited speakers for Pfizer.

1. Gómez-Hernández, A.
2. Sánchez-Galán, E.
3. Ortego, M.
4. Martín-Ventura, J.L.
5. Blanco-Colio, L.M.
6. Tarín-Vicente, N.
7. Jiménez-Nacher, J.J.
8. López-Bescos, L.
9. Egido, J.
10. Tuñón, J.